(Q53929836)

English

Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

author name string

Sulak P

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Lippman J

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Siu C

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Massaro J

4

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Godwin A

5

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

publication date

1 March 1999

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

59

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

161-166

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

A randomized, double-blind study of six combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

Estrogen and progestin components of oral contraceptives: relationship to vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

The efficacy and tolerability of norgestimate/ethinyl estradiol (250 μg of norgestimate/35 μg of ethinyl estradiol): Results of an open, multicenter study of 59,701 women

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

Uniqueness of oral contraceptive progestins.

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

A randomized double-blind trial of two low dose combined oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0010-7824%2899%2900026-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0010-7824(99)00026-8

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/10382078

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53929836&oldid=1386631963"